Virological Surveillance of Acute Respiratory Infection in Primary Health Care in Metropolitan France

Recruiting Observational Study
Respiratory Tract Infections (RTI) Influenza -Like Illness Influenza COVID - 19 RSV Infections Rhinovirus Infection Metapneumovirus Infection
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Any
Study type
Observational
Participants needed
25,000 (estimated)
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France · Government
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Every year in the fall and winter, numerous respiratory viruses (such as influenza viruses, SARS-CoV-2 (COVID-19), RSV, rhinovirus, and metapneumovirus) circulate in mainland France, causing acute respiratory infections (ARIs). These viruses can cause epidemics of varying severity, requiring close monitoring to determine their circulation levels and adapt public health measures accordingly. In Fra…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * be seen by a general practitioner or pediatrician participating in the Sentinelles surveillance program; * between week 40 (late September-early October) and week 15 (mid-April) of each year * have an acute respiratory infection (ARI) as defined below: Sudden onset of fever (o…
Contacts

Thierry BLANCHON, MD, PhD

+33664846662

thierry.blanchon@iplesp.upmc.fr

CONTACT

Olivier STEICHEN, MD, PhD

olivier.steichen@aphp.fr

CONTACT